These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5810099)

  • 21. [Immunochemical analysis of oligosaccharide fragments of O-specific Shigella flexneri polysaccharides].
    Iankina NF; Gomtsian AR; Bakinovskiĭ LV
    Bioorg Khim; 1984 Oct; 10(10):1421-2. PubMed ID: 6083795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of Two Multiplex PCR Assays for Serotyping Shigella flexneri.
    van der Ploeg CA; Rogé AD; Bordagorría XL; de Urquiza MT; Castillo ABC; Bruno SB
    Foodborne Pathog Dis; 2018 Jan; 15(1):33-38. PubMed ID: 29016188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of lipopolysaccharide by strains of Shigella dysenteriae, Shigella flexneri and Shigella boydii and their cross-reacting strains of Escherichia coli.
    Chart H; Daniel RM; Cheasty T
    FEMS Microbiol Lett; 2009 Mar; 292(1):21-6. PubMed ID: 19222579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy.
    Theillet FX; Simenel C; Guerreiro C; Phalipon A; Mulard LA; Delepierre M
    Glycobiology; 2011 Jan; 21(1):109-21. PubMed ID: 21030536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the genetic control of shigella sub-group B type specific antigens. I. Behaviour of Shigella flexneri type specific antigens in sexual recombination of Shigella x E. coli.
    Timakov VD; Petrovskaya VG; Bondarenko VM
    Ann Inst Pasteur (Paris); 1970 Jan; 118(1):3-9. PubMed ID: 4906593
    [No Abstract]   [Full Text] [Related]  

  • 27. Structure and biology of Shigella flexneri O antigens.
    Simmons DA; Romanowska E
    J Med Microbiol; 1987 Jun; 23(4):289-302. PubMed ID: 2438412
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Location of O-acetyl groups in the Shigella flexneri types 3c and 4b lipopolysaccharides.
    Lindberg B; Lönngren J; Romanowska E; Rudén U
    Acta Chem Scand; 1972; 26(9):3808-10. PubMed ID: 4569648
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunochemistry of shigellae. II. O-antigen of Flexner shigellae (chemical structure and relationship to serological properties)].
    Seltmann G
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Jul; (7):20-8. PubMed ID: 331790
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure and genetics of Shigella O antigens.
    Liu B; Knirel YA; Feng L; Perepelov AV; Senchenkova SN; Wang Q; Reeves PR; Wang L
    FEMS Microbiol Rev; 2008 Jul; 32(4):627-53. PubMed ID: 18422615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissemination and serotype modification potential of pSFxv_2, an O-antigen PEtN modification plasmid in Shigella flexneri.
    Sun Q; Knirel YA; Lan R; Wang J; Senchenkova SN; Shashkov AS; Wang Y; Wang Y; Luo X; Xu J
    Glycobiology; 2014 Mar; 24(3):305-13. PubMed ID: 24379081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic changes in Shigella flexneri following conjugation with Escherichia coli HfrC.
    Manson R; Simmons DA; Petrovskaya VG
    Eur J Biochem; 1970 Dec; 17(3):472-6. PubMed ID: 4924195
    [No Abstract]   [Full Text] [Related]  

  • 34. [Shigella surface K-angigens and their role in virulence].
    Belaia IuA; Kostenko LS; Ivanov KK; Petrukhin VG
    Vestn Akad Med Nauk SSSR; 1973; 28(11):35-44. PubMed ID: 4594835
    [No Abstract]   [Full Text] [Related]  

  • 35. Complete genome sequence of Shigella flexneri 5b and comparison with Shigella flexneri 2a.
    Nie H; Yang F; Zhang X; Yang J; Chen L; Wang J; Xiong Z; Peng J; Sun L; Dong J; Xue Y; Xu X; Chen S; Yao Z; Shen Y; Jin Q
    BMC Genomics; 2006 Jul; 7():173. PubMed ID: 16822325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the antigenic structure of shigellae. II. Studies on immunochemistry of Shigella boydii.
    Seltmann G
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):367-75. PubMed ID: 5666681
    [No Abstract]   [Full Text] [Related]  

  • 37. Lysogenic conversion in the Shigella flexneri group.
    Kétyi I; Vertényi A; Financsek I
    Acta Microbiol Acad Sci Hung; 1971; 18(1):47-54. PubMed ID: 4947098
    [No Abstract]   [Full Text] [Related]  

  • 38. Study of the structure of Shigella flexneri O antigen. II. Physicochemical aspect.
    Hannecart-Pokorni E; Dekegel D; Depuydt F; Dirkx J
    Biochim Biophys Acta; 1970 Feb; 201(2):167-78. PubMed ID: 5418718
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic analysis of the lac + hybrid of Escherichia coli K-12 HFRC and variant Y of Shigella flexneri.
    Kolodynski J
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):743-8. PubMed ID: 4946992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.